HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Bristol-Myers Squibb Company (BMY)
59.43  0.63  (1.07%) 07-02 01:32
Open: 59.19 High: 59.73
Pre.close: 58.8 Low: 58.88
Volume: 11,515,061 Ave vol: 16,241,093
52w High: 68.34 52w Low: 42.48
MA(50): 59.741 MA(200): 60.715
EPS: 0.513 P/E Ratio: 115.85
Company profile
Exchange: NYSE
Sector: Healthcare
Industry: Drug ManufacturersGeneral
Website: http://www.bms.com
Market Cap (M): 134,472
Shares Out (M): 2,263
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products in the following therapeutic classes: hematology, oncology, cardiovascular, and immunology. The company's products include Opdivo, a biological product for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia, a biological product for adult patients with active RA and prostate-specific antigen, as well as reducing signs and symptoms in pediatric patients with active polyarticular juvenile idiopathic arthritis.
Technical analysis
Overall: Outperform
MA: Bullish MACD: Bullish
KDJ: Bullish RSI: Bullish
Target 1: 72.61 Target 2: 84.81
Resist 1: 62.17 Resist 2: 72.61
Support 1: 57.16 Support 2: 54.07
Company key metrics
Revenue per Share: 15.3343
Net Income per Share: 2.017
Cash per Share: 7.2411
Book Value per Share: 30.2628
Price to Sales: 4.1613
Price to Book Value: 2.1085
Earnings Yield: 0.0316
Dividend Yield: 0.0246
Debt to Equity: 1.5184
Debt to Assets: 0.6029
Financial analysis
Price to Book Value: Outperform
Return on Assets: Neutral
Return on Equity: Neutral
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Outperform
Stock Charts
Headline news
Wed, 01 Jul 2020
Is Bristol Myers (BMY) a Solid Growth Stock? 3 Reasons to Think ' Yes ' - Yahoo Finance

Mon, 29 Jun 2020
Were Hedge Funds Right About Piling Into Bristol Myers Squibb Company (BMY)? - Yahoo Finance

Wed, 01 Jul 2020
Bristol-Myers Squibb Company (BMY) Rises 1.07% for July 01 - Equities.com

Fri, 26 Jun 2020
Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Special Call (Transcript) - Seeking Alpha

Thu, 25 Jun 2020
3 Reasons Bristol-Myers Squibb Could Make You Rich - Seeking Alpha

Tue, 30 Jun 2020
Bristol Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.